APA (7th ed.) Citation

Li, J., Hou, L., Guo, X., Jin, P., Wu, S., Zhu, J., . . . Zhu, F. (2022). Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: A randomized phase 4 trial. Nature medicine, 28(2), 401-409. https://doi.org/10.1038/s41591-021-01677-z

Chicago Style (17th ed.) Citation

Li, Jingxin, et al. "Heterologous AD5-nCOV Plus CoronaVac Versus Homologous CoronaVac Vaccination: A Randomized Phase 4 Trial." Nature Medicine 28, no. 2 (2022): 401-409. https://doi.org/10.1038/s41591-021-01677-z.

MLA (9th ed.) Citation

Li, Jingxin, et al. "Heterologous AD5-nCOV Plus CoronaVac Versus Homologous CoronaVac Vaccination: A Randomized Phase 4 Trial." Nature Medicine, vol. 28, no. 2, 2022, pp. 401-409, https://doi.org/10.1038/s41591-021-01677-z.